Gossamer Bio, Inc. (GOSS)
NASDAQ
11.69
+0.41 (+3.63%)
Real-time Data
01:30 PM
Day's Range
11.3512.31
52 wk Range
9.12309.60
Financial Statements - GOSS - Gossamer Bio, Inc.
Revenue
48.47M▼ 57.7%
Net Income
-170.37M▼ 201.4%Net Margin -351.5%
EBITDA
-150.99M▼ 277.8%
Free Cash Flow
-171.34M▼ 4840.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 48.47M | 114.70M | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -163.25M | -59.91M | -173.75M | -218.52M | -216.04M | -210.58M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 1.81M | 14.02M | 5.45M | 1.44M | 724K | -23.55M |
| Pre Tax Income | -170.45M | -55.63M | -179.81M | -229.37M | -234M | -243.36M |
| Income Tax | -88K | 893K | - | - | - | - |
| Net Income | -170.37M | -56.52M | -179.81M | -229.37M | -234M | -243.36M |
| EPS Basic | -60 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Diluted | -60 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| Basic Shares Outstanding | 2.85M | 226.22M | 152.62M | 84.57M | 74.84M | 68.51M |
| Diluted Shares Outstanding | 2.85M | 226.22M | 152.62M | 84.57M | 74.84M | 68.51M |
| Ebit | -159.46M | -44.11M | -166.30M | -215.49M | -214.56M | -230.69M |
| Ebitda | -150.99M | -39.96M | -151.92M | -211M | -209.32M | -203.04M |
| Net Income Continuous Operations | -170.37M | -56.52M | -179.81M | -229.37M | -234M | -243.36M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
